Ingredients

Retinol & retinoids

Retinol is the cosmetic-grade form of vitamin A used in dermocosmetic skincare. It sits in a regulated middle ground: less potent than the prescription retinoids tretinoin and adapalene, more biologically active than retinyl esters, and capped in concentration by EU cosmetic law on the basis of SCCS opinions.

At a glance

INCI name

Retinol

Chemical name

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol — vitamin A alcohol

CAS number

68-26-8

Regulatory class

Cosmetic ingredient restricted under Annex III of Regulation (EC) No 1223/2009 (concentration limits adopted following SCCS opinion)

Family

The "retinoids" comprise retinol, retinaldehyde (Retinal), retinyl esters (Retinyl Palmitate, Retinyl Acetate, Retinyl Linoleate), and prescription medicines tretinoin and adapalene (not cosmetic ingredients)

What it is

Retinol is the alcohol form of vitamin A. In the skin, retinol is metabolised first to retinaldehyde and then to retinoic acid (tretinoin), which is the form that binds nuclear retinoic-acid receptors and mediates the family's biological effects on keratinocyte differentiation and dermal extracellular-matrix remodelling. Retinyl esters (palmitate, acetate, linoleate) act as storage forms: they require enzymatic cleavage in the skin before they can be further metabolised.

How it is used in parapharmacy products

Retinol is used in leave-on facial products marketed for textural and tone-related concerns. Concentrations used in formulations have historically ranged from 0.03% to around 1%, though the EU has, following SCCS opinion, adopted upper concentration limits in Annex III of Regulation 1223/2009. The detailed Annex III conditions (maximum concentration in body lotions, in face products and lip products, and total dietary plus cosmetic exposure considerations for the population) should be consulted in the current consolidated text on EUR-Lex; numerical limits are subject to amendment as the science evolves.

Retinaldehyde and retinyl esters are also used cosmetically and are themselves listed in the Annexes with their own conditions where applicable. Prescription retinoids — tretinoin, isotretinoin, adapalene, tazarotene — are medicinal products and are not within cosmetic law. They are reserved to the pharmacy channel and require prescription in EU jurisdictions.

Regulatory status

Following an SCCS opinion that examined cumulative exposure to vitamin A from cosmetics in light of dietary intake, the European Commission has adopted concentration limits and conditions of use for retinol, retinyl acetate and retinyl palmitate in cosmetic products by amendment of Annex III of Regulation (EC) No 1223/2009. The current text on EUR-Lex is the authoritative source for the specific concentration limits in each product category and for required label warnings.

Evidence summary

Evidence on topical retinol from controlled trials, characterised here as well-established for textural and tone-related concerns at cosmetic concentrations, supports a measurable effect on surface roughness, dyspigmentation and fine lines on photo-aged skin. The magnitude of the effect is concentration-dependent and time-dependent: clinical effects typically require sustained use over weeks to months. Cosmetic claims relating to such effects must comply with Commission Regulation (EU) No 655/2013 and must not present the product as a treatment of disease.

The evidence base for tretinoin and adapalene as medicinal products is separate and stronger (these are licensed medicines, with corresponding clinical-trial evidence); cosmetic retinol is not equivalent and should not be presented as such. This site does not give treatment advice; for clinical questions, the appropriate advice is from a pharmacist or physician.

Safety and known considerations

Retinol can cause skin irritation, particularly during the first weeks of use ("retinisation"): erythema, dryness, peeling, and transient burning sensation are common. Photosensitivity has been described, and products are typically labelled with directions for evening use and instructions to apply daytime sun protection.

Vitamin A intake during pregnancy is the subject of established medical guidance because of teratogenic risks at high systemic doses, which is the basis of the prescription-only status of oral isotretinoin. Topical exposure from cosmetic-strength retinol products is typically very low compared with dietary intake, but EU cosmetic labelling reflects the SCCS analysis on this point, and product labels may carry a use-in-pregnancy warning depending on concentration and product type.

Last reviewed: May 2026.